NASDAQ:CDT CDT Equity (CDT) Stock Price, News & Analysis $0.63 -0.17 (-21.57%) Closing price 09/9/2025 04:00 PM EasternExtended Trading$0.65 +0.02 (+3.33%) As of 09:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About CDT Equity Stock (NASDAQ:CDT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CDT Equity alerts:Sign Up Key Stats Today's Range$0.60▼$0.7250-Day Range$0.63▼$2.8752-Week Range$0.60▼$274.80Volume3.73 million shsAverage Volume1.62 million shsMarket Capitalization$1.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited. Read More CDT Equity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks4th Percentile Overall ScoreCDT MarketRank™: CDT Equity scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for CDT Equity. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about CDT Equity's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.11% of the outstanding shares of CDT Equity have been sold short.Short Interest Ratio / Days to CoverCDT Equity has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CDT Equity has recently increased by 123.93%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCDT Equity does not currently pay a dividend.Dividend GrowthCDT Equity does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.11% of the outstanding shares of CDT Equity have been sold short.Short Interest Ratio / Days to CoverCDT Equity has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CDT Equity has recently increased by 123.93%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News Sentiment0.60 News SentimentCDT Equity has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for CDT Equity this week, compared to 1 article on an average week.Search Interest6 people have searched for CDT on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CDT Equity insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.72% of the stock of CDT Equity is held by insiders.Percentage Held by InstitutionsOnly 3.29% of the stock of CDT Equity is held by institutions.Read more about CDT Equity's insider trading history. Receive CDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CDT Equity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDT Stock News HeadlinesShort Interest in CDT Equity Inc. (NASDAQ:CDT) Increases By 123.9%September 4, 2025 | americanbankingnews.comCDT Equity board authorizes adoption of crypto treasury reserve strategySeptember 3, 2025 | msn.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.September 10 at 2:00 AM | Brownstone Research (Ad)CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve StrategySeptember 3, 2025 | markets.businessinsider.comCDT Equity Identifies New Biological Target Validating AI-Driven Repurposing StrategyAugust 26, 2025 | globenewswire.comConduit to Change Name to CDT Equity Inc.August 5, 2025 | finance.yahoo.comCDT Conduit Pharmaceuticals Inc. - Seeking AlphaJuly 11, 2025 | seekingalpha.comConduit Pharmaceuticals Files First Patent for AZD5658 and New Combination Patents for AZD1656 and AZD5658 in Collaboration with Sarborg Limited - NasdaqJuly 9, 2025 | nasdaq.comSee More Headlines CDT Stock Analysis - Frequently Asked Questions How have CDT shares performed this year? CDT Equity's stock was trading at $102.90 at the start of the year. Since then, CDT stock has decreased by 99.4% and is now trading at $0.6252. How were CDT Equity's earnings last quarter? CDT Equity Inc. (NASDAQ:CDT) posted its earnings results on Thursday, August, 14th. The company reported ($5.46) EPS for the quarter. When did CDT Equity's stock split? CDT Equity's stock reverse split on Tuesday, May 20th 2025.The 1-15 reverse split was announced on Friday, May 16th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of CDT Equity? Shares of CDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CDT Equity own? Based on aggregate information from My MarketBeat watchlists, some other companies that CDT Equity investors own include BIOLASE (BIOL), Dare Bioscience (DARE), Faraday Future Intelligent Electric (FFIE), AMC Entertainment (AMC), Cara Therapeutics (CARA), Canoo (GOEV) and Jiuzi (JZXN). Company Calendar Last Earnings8/14/2025Today9/10/2025Next Earnings (Estimated)11/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CDT Previous SymbolNASDAQ:CDT CIK1896212 Webwww.conduitpharma.com Phone760-471-8536FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)($435.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$17.80 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-350.23% Debt Debt-to-Equity RatioN/A Current Ratio1.45 Quick Ratio1.45 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($73.54) per share Price / Book-0.01Miscellaneous Outstanding Shares3,060,000Free Float2,826,000Market Cap$1.91 million OptionableNot Optionable Beta1.92 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:CDT) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CDT Equity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CDT Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
